OPR - Delayed Quote • USD ACIU May 2024 2.500 call (ACIU240517C00002500) Follow 0.2100 -0.0900 (-30.00%) As of April 26 at 9:57 AM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for ACIU240517C00002500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: ACIU We Think AC Immune (NASDAQ:ACIU) Can Afford To Drive Business Growth Further weakness as AC Immune (NASDAQ:ACIU) drops 12% this week, taking three-year losses to 58% AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update AC Immune Announces Upcoming Presentations at AD/PD™ 2024 AbbVie (ABBV) Announces Appointment of New CEO Robert Michael Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround AC Immune to Regain Global Rights to Crenezumab and Semorinemab AC Immune (ACIU) is a Great Momentum Stock: Should You Buy? 5 Small-Cap Stocks to Play the January Effect AC Immune (ACIU) Upgraded to Buy: Here's Why AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases AC Immune Announces Pricing of Underwritten Offering of Common Shares
